Search Results

Prostaglandin E receptor EP1 enhances GABA-mediated inhibition of dopaminergic neurons in the substantia nigra pars compacta and regulates dopamine level in the dorsal striatum

Authors: Tanaka, Yasuhiro; Furuyashiki, Tomoyuki; Momiyama, Toshihiko; Namba, Hisaaki; Mizoguchi, Akira; Mitsumori, Tomoyuki; Kayahara, Tetsuro; Shichi, Hitoshi; Kimura, Kazushi; Matsuoka, Toshiyuki; Nawa, Hiroyuki; Narumiya, Shuh

Source: European Journal of Neuroscience, Volume 30, Number 12, December 2009 , pp. 2338-2346(9)

Publisher: Blackwell Publishing

Inactivation of neuronal forebrain A_2A receptors protects dopaminergic neurons in a mouse model of Parkinson's disease

Authors: Carta, Anna R.; Kachroo, Anil; Schintu, Nicoletta; Xu, Kui; Schwarzschild, Michael A.; Wardas, Jadwiga; Morelli, Micaela

Source: Journal of Neurochemistry, Volume 111, Number 6, December 2009 , pp. 1478-1489(12)

Publisher: Blackwell Publishing

Drugs in the medical treatment of Cushing's syndrome

Author: Schteingart, David E

Source: Expert Opinion on Emerging Drugs, Volume 14, Number 4, December 2009 , pp. 661-671(11)

Publisher: Informa Healthcare

Adverse Endocrine and Metabolic Effects of Psychotropic Drugs: Selective Clinical Review

Authors: Bhuvaneswar, Chaya G.; Baldessarini, Ross J.; Harsh, Veronica L.; Alpert, Jonathan E.

Source: CNS Drugs, Volume 23, Number 12, 1 December 2009 , pp. 1003-1021(19)

Publisher: Adis International

Glutamate Receptors as Therapeutic Targets for Parkinson's Disease

Authors: Johnson, Kari A.; Conn, P. J.; Niswender, Colleen M.

Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets, Volume 8, Number 6, December 2009 , pp. 475-491(17)

Publisher: Bentham Science Publishers

Endogenous Opioids and Addiction to Alcohol and other Drugs of Abuse

Author: Gianoulakis, Christina

Source: Current Topics in Medicinal Chemistry, Volume 9, Number 11, August 2009 , pp. 999-1015(17)

Publisher: Bentham Science Publishers

Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications

Authors: Gaspar, Pablo A.; Bustamante, M. Leonor; Silva, Hernán; Aboitiz, Francisco

Source: Journal of Neurochemistry, Volume 111, Number 4, November 2009 , pp. 891-900(10)

Publisher: Blackwell Publishing

Adenosine A2A Receptors in Psychopharmacology: Modulators of Behavior, Mood and Cognition

Authors: Shen, Hai-Ying; Chen, Jiang-Fan

Source: Current Neuropharmacology, Volume 7, Number 3, September 2009 , pp. 195-206(12)

Publisher: Bentham Science Publishers

Assess the risk of chemotherapy-induced nausea and vomiting, then choose the appropriate prophylactic regimen

Author: Adis International Limited,

Source: Drugs & Therapy Perspectives, Volume 25, Number 10, October 2009 , pp. 17-21(5)

Publisher: Adis International

Dopamine receptor antagonists/trimipramine: Recurrent acute dystonic reactions and oculogyric crisis: 3 case reports

Source: Reactions, Volume 1, Number 1269, 2009-09-12 , pp. 17-17(1)

Publisher: Adis International

The Use of Iontophoresis in the Administration of Nicotine and New Non-Nicotine Drugs through the Skin for Smoking Cessation

Authors: Escobar-Chavez, Jose J.; Merino, Virginia; Lopez-Cervantes, Miriam; Rodriguez-Cruz, Isabel M.a.r.l.e.n.; Quintanar-Guerrero, David; Ganem-Quintanar, Adriana

Source: Current Drug Discovery Technologies, Volume 6, Number 3, September 2009 , pp. 171-185(15)

Publisher: Bentham Science Publishers

The D₃ dopamine receptor inhibits dopamine release in PC-12/hD3 cells by autoreceptor signaling via PP-2B, CK1, and Cdk-5

Authors: Chen, Pei-Chun; Lao, Chu-Lan; Chen, Jin-Chung

Source: Journal of Neurochemistry, Volume 110, Number 4, August 2009 , pp. 1180-1190(11)

Publisher: Blackwell Publishing

Imaging the Glutamate System in Humans: Relevance to Drug Discovery for Schizophrenia

Author: Stone, James M.

Source: Current Pharmaceutical Design, Volume 15, Number 22, August 2009 , pp. 2594-2602(9)

Publisher: Bentham Science Publishers

Blocking Receptor Protein Tyrosine Phosphatase β /ζ: A Potential Therapeutic Strategy for Parkinson's Disease

Authors: Herradon, Gonzalo; Ezquerra, Laura

Source: Current Medicinal Chemistry, Volume 16, Number 25, September 2009 , pp. 3322-3329(8)

Publisher: Bentham Science Publishers

Galantamine improves apomorphine-induced deficits in prepulse inhibition via muscarinic ACh receptors in mice

Authors: Yano, K; Koda, K; Ago, Y; Kobayashi, H; Kawasaki, T; Takuma, K; Matsuda, T

Source: British Journal of Pharmacology, Volume 156, Number 1, January 2009 , pp. 173-180(8)

Publisher: Blackwell Publishing

The effect of naltrexone on amphetamine-induced conditioned place preference and locomotor behaviour in the rat

Authors: Häggkvist, Jenny; Lindholm, Sara; Franck, Johan

Source: Addiction Biology, Volume 14, Number 3, July 2009 , pp. 260-269(10)

Publisher: Blackwell Publishing

Manage nausea and vomiting in terminally ill cancer patients by identifying the cause and selecting appropriate treatment

Author: Adis International Limited,

Source: Drugs & Therapy Perspectives, Volume 25, Number 7, July 2009 , pp. 14-16(3)

Publisher: Adis International

Current investigational drugs for major depression

Authors: Kulkarni, Shrinivas K; Dhir, Ashish

Source: Expert Opinion on Investigational Drugs, Volume 18, Number 6, June 2009 , pp. 767-788(22)

Publisher: Informa Healthcare

Histamine H3-Receptor Inverse Agonists as Novel Antipsychotics

Author: Ito, Chihiro

Source: Central Nervous System Agents in Medicinal Chemistry(Formerly Current Medicinal, Volume 9, Number 2, June 2009 , pp. 132-136(5)

Publisher: Bentham Science Publishers

Tachykinin Receptors as Therapeutic Targets in Stress-Related Disorders

Authors: Ebner, Karl; Sartori, Simone B.; Singewald, Nicolas

Source: Current Pharmaceutical Design, Volume 15, Number 14, May 2009 , pp. 1647-1674(28)

Publisher: Bentham Science Publishers